Efficacy of Intravenous Immunoglobulin Monotherapy in Patients with Cutaneous Lupus Erythematosus: Results of Proof-of-Concept Study - Wikidata - awgldk - TriplyDB

Efficacy of Intravenous Immunoglobulin Monotherapy in Patients with Cutaneous Lupus Erythematosus: Results of Proof-of-Concept Study

Efficacy of Intravenous Immunoglobulin Monotherapy in Patients with Cutaneous Lupus Erythematosus: Results of Proof-of-Concept Study

http://www.wikidata.org/entity/Q35289684

about

Intravenous Immunoglobulins: Mode of Action and Indications in Autoimmune and Inflammatory Dermatoses Therapeutic options for cutaneous lupus erythematosus: recent advances and future prospects.Biological therapies in the treatment of cutaneous lupus erythematosus.Systemic lupus erythematosus diagnosis and management.Lupus community panel proposals for optimising clinical trials: 2018.S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV).Understanding the disease burden and unmet needs among patients with cutaneous lupus erythematosus: A qualitative study

P2860

Q26765226-6EDD8036-2F35-4942-843D-C27E5C922782 Q38850089-D042D461-3EC7-4976-828A-69974009ACEE Q38968255-C1F25B0C-8D3E-476E-A43D-5E4BB7428B2A Q39053129-E9C41D17-0802-4B7E-8E18-7304D8978AA1 Q52320880-A498C5EF-7217-475C-872A-80798E63005A Q52836583-29EE9BDE-4892-48B8-8079-676827685307 Q57179235-A441B230-D4A6-482F-AB69-2B22F1839A19

P2860

Efficacy of Intravenous Immunoglobulin Monotherapy in Patients with Cutaneous Lupus Erythematosus: Results of Proof-of-Concept Study

http://www.wikidata.org/entity/Q35289684

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Efficacy of Intravenous Immuno ...... ults of Proof-of-Concept Study

@ast

Efficacy of Intravenous Immuno ...... ults of Proof-of-Concept Study

@en

type

label

Efficacy of Intravenous Immuno ...... ults of Proof-of-Concept Study

@ast

Efficacy of Intravenous Immuno ...... ults of Proof-of-Concept Study

@en

prefLabel

Efficacy of Intravenous Immuno ...... ults of Proof-of-Concept Study

@ast

Efficacy of Intravenous Immuno ...... ults of Proof-of-Concept Study

@en

P1433

Q35289684-234A6249-F260-4D8E-8890-77EEEFDE6FC7

P1476

Q35289684-92B69217-EF35-4B34-9911-295BACDB8AE4

P2093

Q35289684-408E2634-78AD-4039-8104-EE78933C32A9

Q35289684-4389C213-496A-47C3-8274-9DE2DF449B3A

Q35289684-47DD3C2C-2678-43E8-9A67-9691B8EFFC82

Q35289684-DB7086E4-8DD2-417B-B1AA-89ADEB844A63

Q35289684-E66E3520-D42D-42F9-9B1F-552F9C87F4B0

Q35289684-F831697A-8675-4FB5-A2B5-724B5A571F67

P2860

Q35289684-0718C132-C457-4C01-AE0F-44FCDAB451E2

Q35289684-10C041C3-9A7F-48BF-9126-33E56E167B0B

Q35289684-1650DA77-B431-4DBA-AA6D-B11E5C1EC9F8

Q35289684-178F1583-D2DF-4117-8D01-36522A5AB522

Q35289684-2D651A49-4503-4D74-BCA9-37A1DF103619

Q35289684-31A79B2C-5920-403D-A291-DD31D342AB42

Q35289684-75B6D29D-5B72-4AFA-9DA6-1256395BC352

Q35289684-7E860205-3FC7-4C97-8769-87559EA4BCA5

Q35289684-83A4F7F4-97CA-44F3-8C9B-15BB4E0AE900

Q35289684-89253E7C-5023-4171-8A5C-F59DFCD7467B

P304

Q35289684-01775326-178B-4DA1-ACB5-2C3AC1356D93

P31

Q35289684-C8C03E8A-B1CE-4692-82B4-16E801E0386B

P356

Q35289684-17A914AF-C8D1-409E-93DF-54056242508D

P433

Q35289684-1B7ACE6A-5DB6-40A8-9981-EDA49FD7B0E0

P478

Q35289684-B79ED9ED-B5C2-426D-BDEC-F1C75E772B02

P577

Q35289684-7B394324-E705-470C-98D7-C27D984DB1FC

P5875

Q35289684-318B6708-0153-4E5F-8FFA-D5E5AAB4403F

P698

Q35289684-4738B026-C538-4518-B6E9-2408D7F6E296

P932

Q35289684-C6BEC7C9-5A9B-4C55-8286-1BBB71D5F39D

P356

P1433

Dermatology Reports

P1476

Efficacy of Intravenous Immuno ...... ults of Proof-of-Concept Study

@en

P2093

Brian Swasdibutra

http://www.w3.org/2001/XMLSchema#string

Christa Ky

http://www.w3.org/2001/XMLSchema#string

Sergei A Grando

http://www.w3.org/2001/XMLSchema#string

Shaadi Khademi

http://www.w3.org/2001/XMLSchema#string

Sheetal Desai

http://www.w3.org/2001/XMLSchema#string

Vivian Laquer

http://www.w3.org/2001/XMLSchema#string

P2860

A study of 20 SLE patients with intravenous immunoglobulin--clinical and serologic response.

Efficacy and safety of pulsed dye laser treatment for cutaneous discoid lupus erythematosus.

The cutaneous lupus erythematosus disease area and severity index: a responsive instrument to measure activity and damage in patients with cutaneous lupus erythematosus.

Development of the CLASI as a tool to measure disease severity and responsiveness to therapy in cutaneous lupus erythematosus.

Impact of smoking in cutaneous lupus erythematosus.

The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score.

Issues and advances in the management and pathogenesis of cutaneous lupus erythematosus.

Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.

Efficacy and safety of lenalidomide for refractory cutaneous lupus erythematosus.

Intravenous immunoglobulin in lupus panniculitis.

P304

5804

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4081/DR.2015.5804

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275586096

http://www.w3.org/2001/XMLSchema#string

P698

25918617

http://www.w3.org/2001/XMLSchema#string

P932

4387332

http://www.w3.org/2001/XMLSchema#string